FLAGSTAFF, Ariz., June 20, 2019 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for
managing animal pest populations through fertility control,
announces that AB1788, which will ban the use of Second Generation
Anticoagulant Rodenticides (SGARs), has moved another step closer
to becoming law.
The Environmental Quality committee of the California State
Senate has advanced the California Ecosystems Protection Act
of 2019, which will prohibit the use of the four major Second
Generation Anticoagulant Rodenticides (SGARs) commonly used in
rodent pest control. All anticoagulants have a delay
between consumption of a lethal dose and death of the exposed
organism. As a result the target organism may continue to
consume the bait. In some cases, this allows for super-lethal
concentrations of the rodenticide to accumulate in its body.
Secondary non-target wildlife exposure may occur, when non-target
wildlife feed on the exposed target pest, which still contains the
poison, per the California Senate
Committee on Environmental Quality.
"It was a privilege to be invited to testify before the Senate
committee meeting today to support California's consideration of a bill that will
propel the state forward in its environmental stewardship. I
was joined by our Vice President of Scientific Operations,
Brandy Pyzyna and Dr. Stephen Shuster of Northern
Arizona University," said Dr. Loretta Mayer, Chief Scientific Officer and
co-Founder of SenesTech.
The meeting was well attended by pest management professionals
who, although not in favor of the bill, were informed of an
alternative, ContraPest, that will be available state-wide for
their integrated pest management programs in place of SGARs with
the passage of AB1788.
"Pest management professionals discussed the need for as many
tools in their toolbox as possible to control rodents in
California. Using ContraPest can
help reduce populations before they become risks to businesses and
residents. ContraPest can also help prevent any resistance to SGARs
that are used incorrectly," said Brandy
Pyzyna, Vice President of Scientific Operations and
Technical Services of SenesTech.
"Rodenticide resistant rats also leave progeny that are
rodenticide resistant. This means that stronger or higher
concentrations of toxic chemicals must be applied when the
population of rats, who are all now rodenticide resistant,
rebounds. And they always rebound because their non-resistant
competitors are gone," said Dr. Shuster, Professor of Invertebrate
Zoology at Northern Arizona
University.
The next steps for this bill are to go to the Senate Committee
for Natural Resources, then to the full Senate for approval and
ultimately to Governor Newsome for signature. As this process
moves forward SenesTech continues to prepare to serve the wildlife,
citizens and environment of California.
About SenesTech
SenesTech is changing the paradigm of pest management by
targeting the root cause of the problem: reproduction.
ContraPest® is an innovative technology with an
approach that targets the reproductive capabilities of both sexes
in rat populations, inducing egg loss in female rats and impairing
sperm development in males. Using a proprietary bait delivery
method, ContraPest® is dispensed in a highly palatable
liquid formulation that promotes sustained consumption by rat
communities. ContraPest® is designed, formulated and
dispensed to be low hazard for handlers and non-target species such
as wildlife, livestock and pets, where the active ingredients break
down rapidly.
We believe ContraPest® will establish a new paradigm
in rodent control, resulting in a decreased reliance on lethal
options. For more information visit the SenesTech website at
www.senestech.com.
Safe Harbor Statement
This release contains
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors and other risks
identified in our filings with the Securities and Exchange
Commission. Forward looking statements include, but are not limited
to, our expectation regarding sales commitments, our expectation
regarding the conversion of sales commitments and programs to
revenue, our belief that our product is more humane, less harmful
to the environment and more effective than traditional methods, and
our belief that ContraPest will establish a new paradigm in rodent
control without environmental effects of rodenticides. All
forward-looking statements contained in this press release speak
only as of the date on which they were made and are based on
management's assumptions and estimates as of such date. We do not
undertake any obligation to publicly update any forward-looking
statements, whether as a result of the receipt of new information,
the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum,
Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700,
senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original
content:http://www.prnewswire.com/news-releases/california-bill-to-ban-sgar-rodenticides-clears-senate-environmental-quality-committee-300871837.html
SOURCE SenesTech, Inc.